Insider · CIK 0001897057

Weiss Amir

Reports to the SEC for 1 company · TEL AVIV

sec.gov

Transactions

Companies

Filings

CIK

0001897057

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-21	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	Chief Accounting Officer	SSale	−6,945 sh	$37.61	−$261K	13,071
2026-08-21	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	Chief Accounting Officer	MExercise/Conversion	+2,500 sh	$19.61	+$49K	15,571
2026-08-21	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	Chief Accounting Officer	SSale	−2,500 sh	$37.63	−$94.1K	13,071
2026-08-21	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Stock Options (right to buy)M Exercise/Conversion	Chief Accounting Officer	MExercise/Conversion	−2,500 sh	$19.16	−$47.9K	7,502
2026-05-06	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	Chief Accounting Officer	SSale	−10.7K sh	$36.00	−$384K	20,016
2026-03-05	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	Chief Accounting Officer	MExercise/Conversion	+3,537 sh	—	—	30,695
2026-03-05	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	Chief Accounting Officer	MExercise/Conversion	−3,537 sh	—	—	10,613
2026-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	Chief Accounting Officer	MExercise/Conversion	+10.7K sh	—	—	21,508
2026-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	Chief Accounting Officer	MExercise/Conversion	+5,650 sh	—	—	27,158
2026-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	Chief Accounting Officer	MExercise/Conversion	−10.7K sh	—	—	0
2026-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	Chief Accounting Officer	MExercise/Conversion	−5,650 sh	—	—	11,300
2026-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsA Award	Chief Accounting Officer	AAward	+11.3K sh	—	—	11,280
2026-03-03	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	Chief Accounting Officer	MExercise/Conversion	+5,179 sh	—	—	10,829
2026-03-03	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	Chief Accounting Officer	MExercise/Conversion	−5,179 sh	—	—	5,180
2025-12-16	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	Chief Accounting Officer	SSale	−12.3K sh	$30.20	−$372K	5,650
2025-11-06	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	Chief Accounting Officer	SSale	−12.3K sh	$24.44	−$301K	17,950
2025-03-05	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	Chief Accounting Officer	MExercise/Conversion	+3,566 sh	—	—	30,250
2025-03-05	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	Chief Accounting Officer	MExercise/Conversion	−3,566 sh	—	—	0
2025-03-05	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsA Award	Chief Accounting Officer	AAward	+14.2K sh	—	—	14,150
2025-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	Chief Accounting Officer	MExercise/Conversion	+10.7K sh	—	—	21,034
2025-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	Chief Accounting Officer	MExercise/Conversion	+5,650 sh	—	—	26,684
2025-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	Chief Accounting Officer	MExercise/Conversion	−10.7K sh	—	—	10,679
2025-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	Chief Accounting Officer	MExercise/Conversion	−5,650 sh	—	—	16,950
2025-03-03	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	Chief Accounting Officer	MExercise/Conversion	+5,179 sh	—	—	10,358
2025-03-03	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	Chief Accounting Officer	MExercise/Conversion	−5,179 sh	—	—	10,359
2024-05-16	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	Chief Accounting Officer	SSale	−12.6K sh	$16.65	−$210K	5,179
2024-05-15	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	Chief Accounting Officer	SSale	−15.5K sh	$16.80	−$260K	17,814
2024-03-05	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	Chief Accounting Officer	MExercise/Conversion	+3,564 sh	—	—	33,314
2024-03-05	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	Chief Accounting Officer	MExercise/Conversion	−3,564 sh	—	—	3,566
2024-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	Chief Accounting Officer	MExercise/Conversion	+10.7K sh	—	—	29,750
2024-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	Chief Accounting Officer	MExercise/Conversion	−10.7K sh	—	—	21,355
2024-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsA Award	Chief Accounting Officer	AAward	+22.6K sh	—	—	22,600
2024-03-03	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	Chief Accounting Officer	MExercise/Conversion	+5,179 sh	—	—	19,074
2024-03-03	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	Chief Accounting Officer	MExercise/Conversion	−5,179 sh	—	—	15,538
2024-02-28	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	Chief Accounting Officer	MExercise/Conversion	+3,219 sh	—	—	13,895
2024-02-28	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	Chief Accounting Officer	MExercise/Conversion	−3,219 sh	—	—	0
2024-02-01	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	Chief Accounting Officer	SSale	−31.8K sh	$12.37	−$393K	10,676
2023-08-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	Chief Accounting Officer	SSale	−1,981.41 sh	$9.92	−$19.7K	42,442
2023-03-05	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	Chief Accounting Officer	MExercise/Conversion	+3,564 sh	—	—	41,204.41
2023-03-05	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	Chief Accounting Officer	MExercise/Conversion	−3,564 sh	—	—	7,130
2023-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	Chief Accounting Officer	MExercise/Conversion	+2,406 sh	—	—	26,964.41
2023-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	Chief Accounting Officer	MExercise/Conversion	+10.7K sh	—	—	37,640.41
2023-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	Chief Accounting Officer	MExercise/Conversion	−2,406 sh	—	—	0
2023-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	Chief Accounting Officer	MExercise/Conversion	−10.7K sh	—	—	32,031
2023-03-03	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsA Award	Chief Accounting Officer	AAward	+20.7K sh	—	—	20,717
2023-02-28	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	Chief Accounting Officer	MExercise/Conversion	+3,219 sh	—	—	27,777.41
2023-02-28	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	Chief Accounting Officer	MExercise/Conversion	−3,219 sh	—	—	3,219
2022-03-05	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	Chief Accounting Officer	MExercise/Conversion	+3,564 sh	—	—	24,558.41
2022-03-05	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	Chief Accounting Officer	MExercise/Conversion	−3,564 sh	—	—	10,694
2022-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	Chief Accounting Officer	MExercise/Conversion	+2,403 sh	—	—	20,994.41

Recent filings

Accepted (ET)
Aug 254
Weiss Amir0001193125-26-365116
SEC(opens sec.gov)
May 74
Weiss Amir0001193125-26-211855
SEC(opens sec.gov)
Mar 94
Weiss Amir0001193125-26-098560
SEC(opens sec.gov)
Mar 64
Weiss Amir0001193125-26-096459
SEC(opens sec.gov)
Mar 54
Weiss Amir0001193125-26-093963
SEC(opens sec.gov)
Dec 184
Weiss Amir0001193125-25-324789
SEC(opens sec.gov)
Nov 104
Weiss Amir0001193125-25-274204
SEC(opens sec.gov)
Mar 74
Weiss Amir0000950170-25-035542
SEC(opens sec.gov)
Mar 64
Weiss Amir0000950170-25-034707
SEC(opens sec.gov)

Companies

TEVA PHARMACEUTICAL INDUSTRIES LTDChief Accounting OfficerTEVA

Address

C/O TEVA PHARMACEUTICAL INDUSTRIES LTD. 124 DVORA HANEVI'A ST.,

TEL AVIV, 6944020